✦ LIBER ✦

Development of a safe neutralization assay for SARS-CoV and characterization of S-glycoprotein

✍ Scribed by Dong P Han; Hyung G Kim; Young B Kim; Leo L.M Poon; Michael W Cho

Book ID: 113945987
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 572 KB
Volume: 326
Category: Article
ISSN: 0042-6822
DOI: 10.1016/j.virol.2004.05.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development and evaluation of an efficie

Development and evaluation of an efficient 3′-noncoding region based SARS coronavirus (SARS-CoV) RT-PCR assay for detection of SARS-CoV infections

✍ Huo-Shu H Houng; David Norwood; George V Ludwig; Wellington Sun; Minta Lin; Davi 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 168 KB

A recombinant baculovirus-expressed S gl

A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice

✍ Zhimin Zhou; Penny Post; Rick Chubet; Katherine Holtz; Clifton McPherson; Martin 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 296 KB

Evaluation of a safe and sensitive Spike

Evaluation of a safe and sensitive Spike protein-based immunofluorescence assay for the detection of antibody responses to SARS-CoV

✍ Ivanus Manopo; Liqun Lu; Qigai He; Li Lian Chee; Shzu-Wei Chan; Jimmy Kwang 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 185 KB

A convenient cell fusion assay for the s

A convenient cell fusion assay for the study of SARS-CoV entry and inhibition

✍ YongGang Sha; YingLiang Wu; ZhiJian Cao; XiuLing Xu; WenLan Wu; DaHe Jiang; Xin 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 460 KB

Evaluation of a recombinant nucleocapsid

Evaluation of a recombinant nucleocapsid protein-based assay for Anti-SARS-CoV IgG detection

✍ Paul K.S. Chan; Esther Y.M. Liu; Danny T.M. Leung; Jo L.K. Cheung; C.H. Ma; Fran 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

## Abstract A high throughput accurate assay for anti‐SARS‐CoV IgG detection is needed for large‐scale epidemiological studies. The evaluation of a commercial recombinant nucleocapsid protein‐based microtitre plate enzyme immunoassay, ELISARS™ is described. The results on 150 sera from SARS patient

Evaluation of a novel vesicular stomatit

Evaluation of a novel vesicular stomatitis virus pseudotype-based assay for detection of neutralizing antibody responses to SARS-CoV

✍ Shuetsu Fukushi; Tetsuya Mizutani; Masayuki Saijo; Ichiro Kurane; Fumihiro Taguc 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

Severe acute respiratory syndrome (SARS)-coronavirus (SARS-CoV) is the causative agent of SARS. The S protein of SARS-CoV is a major target for neutralizing antibodies (Nabs) in infected patients. We developed a neutralization assay using a recombinant vesicular stomatitis virus (VSV) bearing SARS-C